Hong Kong pharmaceutical stocks continue to rise, Sanofi Pharmaceutical's shares surged by over 10%.

Hong Kong healthcare stocks continue to rise, with Samsara Pharmaceutical up more than 10%, Tai Ling Pharmaceutical and China Biopharmaceuticals up more than 7%, and Xinda Biotechnology, Stone Pharmaceutical Group, and Rongchang Biotechnology leading the way in terms of gains.